Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001047469-17-002655
Filing Date
2017-04-17
Accepted
2017-04-17 14:18:17
Documents
3
Effectiveness Date
2017-04-17

Document Format Files

Seq Description Document Type Size
1 DEFA14A a2231843zdefa14a.htm DEFA14A 23449
2 G998275.JPG g998275.jpg GRAPHIC 6179
3 G858248.JPG g858248.jpg GRAPHIC 5132
  Complete submission text file 0001047469-17-002655.txt   40314
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Animal Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36714 | Film No.: 17764234
SIC: 2834 Pharmaceutical Preparations